Preclinical Head and Neck Squamous Cell Carcinoma Models for Combined Targeted Therapy Approaches
This study aimed to refine combined targeted approaches on well-characterized, low-passage tumor models. Upon in vivo xenografting in immunodeficient mice, three cell lines from locally advanced or metastatic HNSCC were established. Following quality control and basic characterization, drug response...
Main Authors: | Nina Schoenwaelder, Mareike Krause, Thomas Freitag, Björn Schneider, Sarah Zonnur, Annette Zimpfer, Anne Sophie Becker, Inken Salewski, Daniel Fabian Strüder, Heiko Lemcke, Christina Grosse-Thie, Christian Junghanss, Claudia Maletzki |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-05-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/10/2484 |
Similar Items
-
The Individual Effects of Cyclin-Dependent Kinase Inhibitors on Head and Neck Cancer Cells—A Systematic Analysis
by: Nina Schoenwaelder, et al.
Published: (2021-05-01) -
Identifying Predictive Biomarkers for Head and Neck Squamous Cell Carcinoma Response
by: Anne-Sophie Becker, et al.
Published: (2023-11-01) -
Clinical and Preclinical Targeting of Oncogenic Pathways in PDAC: Targeted Therapeutic Approaches for the Deadliest Cancer
by: Diego J. Jiménez, et al.
Published: (2024-03-01) -
Regression Modeling of the Antioxidant-to-Nephroprotective Relation Shows the Pivotal Role of Oxidative Stress in Cisplatin Nephrotoxicity
by: Alfredo G. Casanova, et al.
Published: (2021-08-01) -
Combined Gemcitabine and Immune-Checkpoint Inhibition Conquers Anti-PD-L1 Resistance in Low-Immunogenic Mismatch Repair-Deficient Tumors
by: Inken Salewski, et al.
Published: (2021-06-01)